United States · FDA National Drug Code directory
Paclitaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0703-3216_26567d69-d05c-44e5-b3ca-e4504aa3c8a6
- Product NDC
- 0703-3216
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Paclitaxel
- Labeler
- Teva Parenteral Medicines, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200325
- Source listing expiry
- 20271231
Source-listed ingredients
- PACLITAXEL — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3216-01) / 16.7 mL in 1 VIAL, MULTI-DOSE · 0703-3216-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →